Sounds Like a Market Niche

Some credit card companies, Visa and Mastercard come to mind, have been looking at raising the fees they charge merchants for using their cards. While the present Wuhan Virus situation has crimped those plans, the delay is only temporary and will last only as long as the virus problem and associated economic problem lasts. The fee increases, though, when they are implemented,

in some cases would be hardest on small businesses[.]

After all,

the abrupt global slowdown has been most acute for the smallest businesses, which tend to operate on thinner profit margins and smaller cash reserves.

Such a move by the major credit card players would seem to create a market niche. Maybe small businesses—perhaps by industry association, perhaps by geographic association, perhaps generally—could band together to create, issue, and support their own credit card(s). Bypassing the name cards and bypassing the banks that issue them also would allow the small business card issuers to charge a lower fee for use of the cards.

Which, ultimately, would be good for the businesses’ customers, and so for the businesses, a multi-win situation.  Small businesses in these new credit card associations would find their costs lowered—no longer having to pay the major card players such high fees—and so fewer costs to pass on to their customers or to eat, and so more customers entering their stores.

We’re Not the only Ones

There’s this bit, via The Independent, a British online news publication, regarding the reliability of (medical) products from the People’s Republic of China:

The UK government’s new testing chief has admitted that none of the 3.5 million antibody tests ordered from [the People’s Republic of China] are fit for widespread use.
Professor John Newton, who was appointed by health secretary Matt Hancock to oversee testing, reportedly said the tests were only able to identify immunity in people who had been severely sick with coronavirus.
The tests did not pass the evaluation stage, and he was quoted by The Times as saying they were “not good enough to be worth rolling out in very large scale”.

The Brits, too—along with, I strongly suspect, all of Europe, North and South America, the Middle East, and on and on—need to adjust the supply chains of their nationally critical items so as to eliminate the PRC from them.

It’s generally appropriate not to ascribe to malevolence what incompetence can adequately explain. However, sometimes it really is malevolence, when it’s on the scale the PRC is perpetrating.